by Tawny Hammett, M.S. JHU Alumna The COVID-19 pandemic has transcended a mere influenza-like disease, showcasing a range of severity from mild cold symptoms to multi-organ failure and death1. Given…
Read More
by Yazmin I. Rovira Gonzalez, Ph.D., JHU Alumna CRISPR-Cas9 technology is a powerful tool for editing genomes, as it allows researchers to alter DNA sequences and modify gene function. It…
John Jones, M.S. Biotechnology Johns Hopkins University Alumnus In 1796, Edward Jenner devised a method to protect individuals from smallpox by using blisters of someone infected with cowpox to inoculate…
Tawny Hammett, M.S. Individualized Genomics & Health Johns Hopkins University Alumna The COVID-19 pandemic is slowly starting to makes its way to a period of tenuous recovery, bringing a welcomed…
Yazmin I. Rovira Gonzalez, PhD, Johns Hopkins UniversityAlumna On May 18th 2020, Moderna, Inc. – a clinical-stage biotechnology company focused on mRNA technologies, including messenger RNA-based vaccines and therapies –…
